Genetics of hereditary colon cancer: A model for prevention

Canadian Journal of Surgery

Volumn 41, Issue 5, 1998, Pages 345-350

  Stern, Hartley ^a,b   Lagarde, Alain ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN;

ADENOMATOUS POLYP; ALLELE; CARCINOGENESIS; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; FAMILIAL CANCER; GENETIC PREDISPOSITION; HUMAN; JEW; MODEL; MOLECULAR GENETICS; ONCOGENE; REVIEW; SIGMOIDOSCOPY; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; GENES, APC; GENETIC SCREENING; HUMANS; MUTATION; MUTS HOMOLOG 2 PROTEIN; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031667358     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Stern HS. Contributions of molecular genetics to the clinical management of colorectal cancer. Am J Surg 1996;171:10-5.
2. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-50.
3. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients [see comment]. Nat Med 1996;2(2):169-74. Comment in: Nat Med 1996;2(2):156-8
4. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients [see comment]. Nat Med 1996;2(2):169-74. Comment in: Nat Med 1996;2(2):156-8
5. Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis [see comments]. Lancet 1996;348(9025):433-5. Comments in: Lancet 1996;348(9025):422; Lancet 1997;350(9093):1777.
6. Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis [see comments]. Lancet 1996;348(9025):433-5. Comments in: Lancet 1996;348(9025):422; Lancet 1997;350(9093):1777.
7. Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis [see comments]. Lancet 1996;348(9025):433-5. Comments in: Lancet 1996;348(9025):422; Lancet 1997;350(9093):1777.
8. Stern HS, Smith A. Recognition, screening and medical management of familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:19-24.
9. Nugent KP, Phillips RK. Rectal cancer risk in patients treated for familial adenomatous polyposis and an ileorectal anastomosis. A cause for concern. Br J Surg 1992;79:1204-6.
10. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997;17(1):79-83.
11. Lynch, HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer 1971;27:1505-11.
12. Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, et al. Genetic mapping of a locus predisposing to human colorectal cancer [see comment]. Science 1993;260 (1509):810-2. Comment in: Science 1993;260(1509):751.
13. Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, et al. Genetic mapping of a locus predisposing to human colorectal cancer [see comment]. Science 1993;260 (1509):810-2. Comment in: Science 1993;260(1509):751.
14. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colorectal cancer. Nat Genet 1993;5(3):279-82.
15. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
16. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 1993;53(24):5853-5.
17. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutation gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. cell 1994;77(1):167.
18. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995;55(23):5548-50.
19. Vasen HF, Wijnen JT, Menko FH, Kleibenker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis [published erratum appears in Gastroenterology 1996;111(5):1402]. Gastroenterology 1996;110:1020-7
20. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994;14(4B): 1631-4.
21. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLHl-associated hereditary colorectal cancer [see comment]. Gastroenterology 1996;110:682-7. Com- ment in: Gastroenterology 1996;110(3): 943-7.
22. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLHl-associated hereditary colorectal cancer [see comment]. Gastroenterology 1996;110:682-7. Com- ment in: Gastroenterology 1996;110(3): 943-7.
23. Lanspa SJ, Jenkins JX, Cavalieri RJ, Smyrk TC, Watson P, Lynch J, et al. Surveillance in Lynch syndrome: How aggressive? Am J Gastroenterol 1994;89 (11):1978-80.
24. Mecklin JP, Jarvinen H. Treatment and follow-up strategies in hereditary non-polyposis colorectal cancer. Dis Colon Rectum 1993;36:927-9.
25. Watson P, Lynch HT. The tumor spectrum in HNPCC. Anticancer Res 1994;14:1635-41.
26. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis [see comments]. N Engl J Med 1997:336:823-7. Comments in: N Engl J Med 1997;336(12):869-70; N Engl J Med 1997;337(4):282.
27. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis [see comments]. N Engl J Med 1997:336:823-7. Comments in: N Engl J Med 1997;336(12):869-70; N Engl J Med 1997;337(4):282.
28. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis [see comments]. N Engl J Med 1997:336:823-7. Comments in: N Engl J Med 1997;336(12):869-70; N Engl J Med 1997;337(4):282.
29. Cole DE, Gallinger S, McCready DR, Rosen B, Engel J, Malkin D. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: Where are we today? CMAJ 1996;154(2);149-55.